Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
This study aims to evaluate the efficiency of calcium and vitamin D in treating adults diagnosed with osteoporosis caused by corticosteroid therapy.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Publisher article type: review-article
Source: Publisher publication metadata.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Full studies
Evaluation of the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis
Review / evidence synthesis · Medicine · 2021
Original publication title
Evaluation of the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Study background
What background does the paper provide?
Osteoporosis is a condition that deteriorates the skeletal system progressively and systemically. The indicators include diminished bone mass and micro-architectural deterioration of bone tissue. Resultantly, the bones are increasingly fragile and highly prone to fractures.[1] The incidence of fractures related to osteoporosis increases sharply with age, from 4% in females aged 50 to 59 to 52% in females aged more than 80 years.[2] Numerous risk factors are related to the development of osteoporosis, such as gender, age, genetic factors, ethnicity, reproductive status, reduced intake of calcium, unhealthy lifestyle, and certain illnesses.[3] Individuals having inflammatory disorders face an elevated risk of developing osteoporosis due to their underlying diseases and frequent intake of corticosteroids.
Steroids are widely utilized as a treatment method for bronchial asthma, inflammatory bowel disease, rheumatic disorders, organ transplants, malignant lymphomas, and multiple myeloma. Corticosteroid therapy suppresses the formation of bones and impedes the absorption of Calcium in the intestine, which leads to bone loss and fractures and ultimately to secondary hyperparathyroidism and elevated osteoclastic bone resorption.[4,5] Histomorphometrically, the bone formation rate and trabecular bone volume are reduced.[6] The objectives of treatment include averting bone fractures, sustaining the BMD, and refining physical functions.
Calcium and vitamin D are regarded to be at the core of the treatment process in post-menopausal osteoporosis.[3] Several studies investigated how Calcium and Vitamin D affected adult patients with corticosteroid-induced osteoporosis; however, the reported results are not conclusive.[7Not reported10] Thus, this study will be undertaken to evaluate the efficiency of calcium and vitamin D in treating adult patients with corticosteroid-induced osteoporosis.
Source: IntroductionStudy methods
What methods does the paper describe?
Study registration
This study is funded through a protocol registry in the Open Science Framework (OSF, http://osf.io/). The registration DOI number is 10.17605/OSF.IO/ZVB38. The protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocol statement guidelines.
Inclusion criteria for study selection
Types of studies
Regardless of the publication status, this review will include all available studies based on the study method of randomized controlled trials (RCTs) that evaluates the efficacy of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis. The language was restricted to publications in English. Case reports, conferences, reviews, non-RCTs, and non-human studies will be excluded.
Types of participants
All study subjects identified with osteoporosis are included. Patients must take corticosteroids throughout the trial. Patients who had received calcitonin, anti-coagulant drug therapy, and those with any illnesses that might affect bone metabolism will be excluded.
Types of interventions
All study participants will be administered vitamin D with calcium as opposed to vitamin D only, calcium only, or placebo in treating adult patients with corticosteroid-induced osteoporosis.
Types of outcome measures
In this review, the principal outcome measure includes a percentage variation in bone mineral density from the reference. The secondary outcome measures include drop-outs due to side effects, fracture incidence, and 24 hours hydroxyproline excretion.
Data sources and search strategy
Electronic searches
Studies that evaluate the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis will be sourced from PubMed, EMBASE, the Cochrane Library, Scopus, and Web of Science. The time scope is limited from their inception to November 2020. The combination of keywords and free text retrieval is adopted. The following key terms will be used for the search: osteoporosis∗, corticosteroid∗, steroids∗, calcium∗, “vitamin D”.
Other resources
Moreover, this study will also refer to the reference lists of the selected studies and search ClinicalTrials.gov (www.ClinicalTrials.gov) and Google scholar to find grey literature.
Data collection and analysis
Selection of studies
Based on the eligibility criteria defined previously, 2 authors will autonomously screen the related studies. Once any duplicates are removed, the titles and abstracts and will be examined. Following a review of the full-text of the preliminary selective papers, the selection of eligible studies is based on our pre-determined inclusion criteria. All disagreements will be resolved through discussion. Figure 1. illustrates the details of the entire selection process.
The research flowchart.
Data extraction and management
Data extraction will be performed autonomously by 2 authors. The process will use a standard designed data extraction table. The following information will be extracted: first author, publication date, race, gender, disease duration, study method, sample size, intervention details, outcomes, and other associated information. All disagreements will be resolved through discussion.
Risk of bias assessment
The risk of bias in the included studies will be autonomously evaluated by 2 authors, the process will be based on the Cochrane Collaboration's “Risk of bias” tool.[11]
Measures of treatment effect
Risk ratios with 95% confidence interval will be used to calculate dichotomous outcomes, and mean difference or standardized mean difference (SMD) with 95% confidence interval to calculate continuous outcomes.
Assessment of heterogeneity
I2 statistic and the Cochrane's Q test will be used to estimate the heterogeneity among the included studies. Accordingly, an I2 > 50% or P < .1 infers substantial heterogeneity, in which case, the random-effects model will be adopted to merge the results; else, the fixed-effects model is adopted to merge the results.
Assessment of reporting biases
If the number of include studies is more than ten, funnel plots are used to assess the risk of publication bias.[12]
Sensitivity analysis
It is planned to carry out a sensitivity analysis to evaluate the robustness of our findings by excluding low-quality studies.
Abstract: Ethics and dissemination
Since this systematic review does not involve any human or animal participants, an ethics approval is not required.
Source: Ethics and dissemination:Abstract: Systematic review registration
Aug 19, 2021. osf.io/zvb38. (https://osf.io/zvb38/).
Source: Systematic review registration:Discussion
To date, there are no reports for evaluating the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis. Recently, an increasing number of studies have investigated the efficacy of calcium and vitamin D for treating adults with corticosteroid-induced osteoporosis. However, the results of these studies are not conclusive. Therefore, this study is conducted to investigate the efficiency of Calcium and Vitamin D in treating adult patients with corticosteroid-induced osteoporosis. Furthermore, this study also provides helpful recommendations for clinicians and future research on using calcium and vitamin D to treat adult patients with corticosteroid-induced osteoporosis.
Source: DiscussionAbstract: Results
This study will provide additional practical and targeted results of evaluating the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis.
Source: Results:Abstract: Conclusion
The results of this study will provide further evidence about calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis, clinicians and policymakers can make practical use of the results.
Source: Conclusion:Authors’ abstract
Abstract
Background:
Administering corticosteroid is an effective therapeutic strategy for treating most inflammatory conditions. However, there is a chance for corticosteroid treatment to adversely affect bones, resulting in corticosteroid-induced osteoporosis, which is a highly prevalent type of secondary osteoporosis. Elevated bone resorption and reduced formation of bone are pathogenesis indicators of corticosteroid-induced osteoporosis. Preventative therapy is recommended for patients initiating steroids. This study aims to evaluate the efficiency of calcium and vitamin D in treating adults diagnosed with osteoporosis caused by corticosteroid therapy.
Methods:
Electronic databases will be searched systematically to source studies that have evaluated the efficiency of calcium and vitamin D as a treatment method for adult patients with osteoporosis from corticosteroid therapy. The databases include, PubMed, EMBASE, the Cochrane Library, Scopus, and Web of Science. The timeline of the search will be limited from inception to November 2020. This study will utilize the Cochrane risk of bias tool to assess the quality of the studies reviewed. Moreover, appropriate methods will be chosen to analyze the data.
The RevMan 5.3 software is utilized to perform statistical analysis.
Results:
This study will provide additional practical and targeted results of evaluating the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis.
Conclusion:
The results of this study will provide further evidence about calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis, clinicians and policymakers can make practical use of the results.
Ethics and dissemination:
Since this systematic review does not involve any human or animal participants, an ethics approval is not required.
Systematic review registration:
Aug 19, 2021. osf.io/zvb38. (https://osf.io/zvb38/).
Read the full paper
Introduction
Osteoporosis is a condition that deteriorates the skeletal system progressively and systemically. The indicators include diminished bone mass and micro-architectural deterioration of bone tissue. Resultantly, the bones are increasingly fragile and highly prone to fractures.[1] The incidence of fractures related to osteoporosis increases sharply with age, from 4% in females aged 50 to 59 to 52% in females aged more than 80 years.[2] Numerous risk factors are related to the development of osteoporosis, such as gender, age, genetic factors, ethnicity, reproductive status, reduced intake of calcium, unhealthy lifestyle, and certain illnesses.[3] Individuals having inflammatory disorders face an elevated risk of developing osteoporosis due to their underlying diseases and frequent intake of corticosteroids.
Steroids are widely utilized as a treatment method for bronchial asthma, inflammatory bowel disease, rheumatic disorders, organ transplants, malignant lymphomas, and multiple myeloma. Corticosteroid therapy suppresses the formation of bones and impedes the absorption of Calcium in the intestine, which leads to bone loss and fractures and ultimately to secondary hyperparathyroidism and elevated osteoclastic bone resorption.[4,5] Histomorphometrically, the bone formation rate and trabecular bone volume are reduced.[6] The objectives of treatment include averting bone fractures, sustaining the BMD, and refining physical functions.
Calcium and vitamin D are regarded to be at the core of the treatment process in post-menopausal osteoporosis.[3] Several studies investigated how Calcium and Vitamin D affected adult patients with corticosteroid-induced osteoporosis; however, the reported results are not conclusive.[7Not reported10] Thus, this study will be undertaken to evaluate the efficiency of calcium and vitamin D in treating adult patients with corticosteroid-induced osteoporosis.
Methods
Study registration
This study is funded through a protocol registry in the Open Science Framework (OSF, http://osf.io/). The registration DOI number is 10.17605/OSF.IO/ZVB38. The protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocol statement guidelines.
Inclusion criteria for study selection
Types of studies
Regardless of the publication status, this review will include all available studies based on the study method of randomized controlled trials (RCTs) that evaluates the efficacy of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis. The language was restricted to publications in English. Case reports, conferences, reviews, non-RCTs, and non-human studies will be excluded.
Types of participants
All study subjects identified with osteoporosis are included. Patients must take corticosteroids throughout the trial. Patients who had received calcitonin, anti-coagulant drug therapy, and those with any illnesses that might affect bone metabolism will be excluded.
Types of interventions
All study participants will be administered vitamin D with calcium as opposed to vitamin D only, calcium only, or placebo in treating adult patients with corticosteroid-induced osteoporosis.
Types of outcome measures
In this review, the principal outcome measure includes a percentage variation in bone mineral density from the reference. The secondary outcome measures include drop-outs due to side effects, fracture incidence, and 24 hours hydroxyproline excretion.
Data sources and search strategy
Electronic searches
Studies that evaluate the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis will be sourced from PubMed, EMBASE, the Cochrane Library, Scopus, and Web of Science. The time scope is limited from their inception to November 2020. The combination of keywords and free text retrieval is adopted. The following key terms will be used for the search: osteoporosis∗, corticosteroid∗, steroids∗, calcium∗, “vitamin D”.
Other resources
Moreover, this study will also refer to the reference lists of the selected studies and search ClinicalTrials.gov (www.ClinicalTrials.gov) and Google scholar to find grey literature.
Data collection and analysis
Selection of studies
Based on the eligibility criteria defined previously, 2 authors will autonomously screen the related studies. Once any duplicates are removed, the titles and abstracts and will be examined. Following a review of the full-text of the preliminary selective papers, the selection of eligible studies is based on our pre-determined inclusion criteria. All disagreements will be resolved through discussion. Figure 1. illustrates the details of the entire selection process.
The research flowchart.
Data extraction and management
Data extraction will be performed autonomously by 2 authors. The process will use a standard designed data extraction table. The following information will be extracted: first author, publication date, race, gender, disease duration, study method, sample size, intervention details, outcomes, and other associated information. All disagreements will be resolved through discussion.
Risk of bias assessment
The risk of bias in the included studies will be autonomously evaluated by 2 authors, the process will be based on the Cochrane Collaboration's “Risk of bias” tool.[11]
Measures of treatment effect
Risk ratios with 95% confidence interval will be used to calculate dichotomous outcomes, and mean difference or standardized mean difference (SMD) with 95% confidence interval to calculate continuous outcomes.
Assessment of heterogeneity
I2 statistic and the Cochrane's Q test will be used to estimate the heterogeneity among the included studies. Accordingly, an I2 > 50% or P < .1 infers substantial heterogeneity, in which case, the random-effects model will be adopted to merge the results; else, the fixed-effects model is adopted to merge the results.
Assessment of reporting biases
If the number of include studies is more than ten, funnel plots are used to assess the risk of publication bias.[12]
Sensitivity analysis
It is planned to carry out a sensitivity analysis to evaluate the robustness of our findings by excluding low-quality studies.
Discussion
To date, there are no reports for evaluating the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis. Recently, an increasing number of studies have investigated the efficacy of calcium and vitamin D for treating adults with corticosteroid-induced osteoporosis. However, the results of these studies are not conclusive. Therefore, this study is conducted to investigate the efficiency of Calcium and Vitamin D in treating adult patients with corticosteroid-induced osteoporosis. Furthermore, this study also provides helpful recommendations for clinicians and future research on using calcium and vitamin D to treat adult patients with corticosteroid-induced osteoporosis.
Author contributions
Conceptualization: Song-Li Pan.
Data curation: Song-Li Pan, Chen-Cui Li, Hong-Wang Cui, Wen-Xian Wang, Chun-Hong Li.
Formal analysis: Song-Li Pan, Chen-Cui Li, Hong-Wang Cui, Wen-Xian Wang, Chun-Hong Li.
Funding acquisition: Song-Li Pan, Chun-Hong Li.
Investigation: Chen-Cui Li, Wen-Xian Wang, Chun-Hong Li.
Methodology: Song-Li Pan, Chen-Cui Li, Hong-Wang Cui, Chun-Hong Li.
Project administration: Song-Li Pan, Wen-Xian Wang, Chun-Hong Li.
Resources: Hong-Wang Cui, Chun-Hong Li.
Software: Song-Li Pan, Chen-Cui Li, Hong-Wang Cui, Wen-Xian Wang.
Supervision: Wen-Xian Wang, Chun-Hong Li.
Validation: Song-Li Pan, Chen-Cui Li, Hong-Wang Cui.
Visualization: Song-Li Pan, Chun-Hong Li.
Writing: original draft: Song-Li Pan, Chun-Hong Li.
Writing: review & editing: Chun-Hong Li.
How to cite this article: Pan SL, Li CC, Cui HW, Wang WX, Li CH. Evaluation of the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis: a protocol for systematic review and meta-analysis. Medicine. 2021;100:39(e27197).
S-LP and C-CL contributed equally to this work.
This work was supported by a grant from the Natural Science Foundation of Hainan Province (Grant Number: 817140). The sponsors had no role in the present protocol.
The authors have no conflicts of interests to disclose.
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Publication and source details
Original title: Evaluation of the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis
Song-Li Pan; Chen-Cui Li; Hong-Wang Cui; Wen-Xian Wang; Chun-Hong Li
Medicine · 2021
∗ Correspondence: Chun-Hong Li, The First Affiliated Hospital of Hainan Medical University, 31, Longhua RD, Haikou 570102, Hainan, China (e-mail: lichunhong19831201@163.com).Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.2021https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0Natural Science Foundation of Hainan Province817140Song-Li PanRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T11:58:05.882691+00:00
DOI: 10.1097/md.0000000000027197 · PMC8483843